Buy Amedisys

Logo for stock AMED (Amedisys)

Amount

£
GBP

Latest price

$92.59
(£1.00 = $1.295)

Number of shares (est.)

0

Start investing today

Open an investment account in Emma and enjoy commission free stock trading. Capital at risk, other charges apply.

QR code linking to downloads for the Emma app.
Download on the App Store buttonGet it on Google Play button

Metrics

Market Cap

$3.031B

P/E ratio

70.62

EPS

$1.308

Beta

0.91

Dividend rate

N/A

Dividend yield

N/A

About

Amedisys, Inc. is a healthcare service company. The Company is engaged in providing care and support in the home. It delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.

CEO

Mr. Richard M. Ashworth

Employees

19,000

Sector

Health

Company HQ

BATON ROUGE, United States of America

News

Logo for news article #0 (AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises)

AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.

Zacks Investment Research

March 03, 2025

Logo for news article #1 (Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say)

Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research

February 27, 2025

Logo for news article #2 (Amedisys (AMED) Lags Q4 Earnings and Revenue Estimates)

Amedisys (AMED) Lags Q4 Earnings and Revenue Estimates

Amedisys (AMED) came out with quarterly earnings of $0.96 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.94 per share a year ago.

Zacks Investment Research

February 26, 2025

Emma logo
Facebook logoTiktok logoTwitter / X logoInstagram logo

© 2025 Emma Technologies Ltd. All Rights Reserved.

Emma is registered and incorporated in England and Wales.

Emma Technologies Ltd is an appointed representative of RiskSave Technologies Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 775330).

Payment services (Non MIFID or Deposit related products) for Emma Technologies Ltd are provided by The Currency Cloud Limited. Registered in England No. 06323311. Registered Office: Stewardship Building 1st Floor, 12 Steward Street London E1 6FQ. The Currency Cloud Limited is authorised by the Financial Conduct Authority under the Electronic Money Regulations 2011 for the issuing of electronic money (FRN: 900199). For more detail on how your money is protected please see here. You can also find Currency Cloud's Terms of Use here.

Emma Technologies Ltd is an Introducer Appointed Representative of Quint Group Limited, which is authorised and regulated by the Financial Conduct Authority (FRN 669450). Emma Technologies Ltd is not a lender. Emma Technologies Ltd introduces customers to Monevo Limited who is a licensed credit broker.

Emma is registered with the Financial Conduct Authority under the Payment Services Regulations 2017 for the provision of payment services.

Financial Conduct Authority Reg Nr: 794952.
Company Registration Number: 10578464.
Data Protection Registration Number: ZA241546.

All testimonials, reviews, opinions or case studies presented on our website may not be indicative of all customers. Results may vary and customers agree to proceed at their own risk.